- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT07946861
Intramedullary Nailing for Femoral Shaft Fractures
Comparative Effectiveness Randomized Controlled Trial of Micromotion vs Non-micromotion Intramedullary Nailing for Femoral Shaft Fractures
A randomized controlled trial that is trying to find the best treatment for a severe upper leg (i.e., thigh, also known as femoral shaft) fracture. One type of treatment, which is called micromotion intramedullary (within the hollow center of the bone) nailing, is a type of nail used for thigh fracture treatments that helps to heal the bone by allowing a small amount of controlled movement. Another type, called non-micromotion intramedullary nailing, is also used to treat thigh fractures but does not include this controlled-movement feature. Both treatments are approved by the FDA but have not been directly compared to each other. Participation includes being assigned to receive either a micromotion intramedullary nail or a non-micromotion intramedullary nail. Those that participate will be randomly assigned (like a flip of a coin) to one of those treatment methods and return for standard follow-up visits. In addition to those regular clinical follow-ups, participants will complete some brief surveys/questionnaires while they are in the hospital. Research staff will also look at past medical history.
Descripción general del estudio
Estado
Condiciones
Intervención / Tratamiento
Tipo de estudio
Inscripción (Estimado)
Fase
- No aplica
Contactos y Ubicaciones
Ubicaciones de estudio
-
-
Indiana
-
Indianapolis, Indiana, Estados Unidos, 46202
- Reclutamiento
- Indiana University Health Methodist Hospital
-
Investigador principal:
- Roman Natoli, MD, PhD
-
Contacto:
- Cora F Mizimakoski, Bachelor of Science
- Número de teléfono: 317-963-5034
- Correo electrónico: cmizimak@iu.edu
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Descripción
Inclusion Criteria:
- Patients aged 18-84 years old inclusive with a femoral shaft fracture deemed appropriate for treatment with an IMN by the treating surgeon
Exclusion Criteria:
- Not within age range
- Planned treatment with dominant implants other than IMN
- Non-ambulatory at baseline
- Fracture needs a planned-staged secondary procedure for bone defects (e.g., Masquelet)
- Any previous surgery on the index site
- Fracture fixation >28 days from injury
- Fractures that the treating surgeon indicates require any additional fixation that spans the fracture. These patients will be late ineligible
- Patients with a history of infection or a current active infection at the surgical site
- Patients undergoing revision surgery following primary fixation
- Patients undergoing femoral nailing for a pathological fracture
- Patients undergoing bone transport over an intramedullary nail
- Non-English or Non-Spanish speaking
- Prisoners or impending incarceration
- Patients unwilling or unable to participate in study protocol or follow up in the IU system for 12 months
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Tratamiento
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Ninguno (etiqueta abierta)
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Comparador activo: Standard Intramedullary Nailing
|
A rod inserted into the hollow center of a long bone to hold a broken bone in place while it heals. |
|
Experimental: OrthoXel Micromotion Intramedullary Nail
|
An intramedullary nail that allows for controlled axial micromotion. |
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Periodo de tiempo |
|---|---|
|
Superiority of micromotion nailing over non-micromotion IMN according to a composite outcome using a win ratio reflective of improved femoral shaft fracture healing
Periodo de tiempo: From enrollment to end of treatment at about a year.
|
From enrollment to end of treatment at about a year.
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Iindividual levels of the win-ratio pyramid between the micromotion nailing and non-micromotion nailing groups.
Periodo de tiempo: From enrollment to end of treatment at about a year.
|
From enrollment to end of treatment at about a year.
|
|
|
Superiority of micromotion nailing in a subgroup of patients at high baseline risk for nonunion.
Periodo de tiempo: From enrollment to end of treatment at about a year.
|
From enrollment to end of treatment at about a year.
|
|
|
Number of patients with Adverse Events and Complications between the Micromotion nail and standard of care intramedullary nails.
Periodo de tiempo: From enrollment to end of treatment at about a year.
|
From enrollment to end of treatment at about a year.
|
|
|
Change in daily step count from pre-injury baseline between the micromotion nailing and non-micromotion nailing groups.
Periodo de tiempo: From enrollment to end of treatment at about a year.
|
Daily step count, measured in steps per day, will be obtained from the Apple Health app on the participant's iPhone. Participants will download the OrthoSteps app once to transfer their Apple Health data to the study team. Step counts will be assessed at the pre-injury baseline and at each post-injury follow-up. |
From enrollment to end of treatment at about a year.
|
|
Gait balance between the two groups as calculated by the GaitMap.
Periodo de tiempo: From enrollment to end of treatment at about a year
|
From enrollment to end of treatment at about a year
|
|
|
Walking speed using a GaitMap
Periodo de tiempo: From enrollment to end of treatment at about a year.
|
From enrollment to end of treatment at about a year.
|
|
|
Modified Radiographic union scores for femoral shaft fractures
Periodo de tiempo: From enrollment to end of treatment at about a year.
|
From enrollment to end of treatment at about a year.
|
Colaboradores e Investigadores
Patrocinador
Colaboradores
Investigadores
- Investigador principal: Roman Natoli, MD, PhD, Indiana University
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Actual)
Finalización primaria (Estimado)
Finalización del estudio (Estimado)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Otros números de identificación del estudio
- 29753
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
producto fabricado y exportado desde los EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .